COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
16/08/2018
FIT Biotech Oy Company release August 16, 2018 at 04:15 PM EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]
Zealand Pharma - Interim report for the first half of 2018
16/08/2018
Company announcement - No. 20 / 2018 Zealand Pharma - Interim report for the first half of 2018 Copenhagen, August 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), a Copenhagen-based [...]
FIT Biotech Oy: Chairman of the board on leave of absence
16/08/2018
FIT Biotech Oy Company release 16.8.2018 at 04:00 PM EET Chairman of the board on leave of absence FIT Biotech's ("FIT Biotech", FITBIO: FN Finland) chairman of the board, Rabbe Slätis, has announced an indefinite leave [...]
ATW Tech Announces the Release of the New Branding for Its Voting System
16/08/2018
MONTREAL, Aug. 16, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ATW Tech”’ the “Company”) (TSX-V: ATW) announces today the release of the new branding for its voting system. ATW Tech is proud to announce that its prominent [...]
ATW Tech annonce le lancement de sa nouvelle marque pour son système de votation
16/08/2018
MONTRÉAL, 16 août 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech » ou la « Société ») (TSX-V: ATW) annonce aujourd’hui le lancement de sa nouvelle marque de commerce pour son système de votation. ATW Tech est fier d [...]
Agritek Holdings, Inc. Announces Filing Extension And Delay In Form 10-Q Report With Full Intention Of Remaining Fully Reporting And Uplisted On OTCQB
16/08/2018
LOS ANGELES, CA, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the United States and Canada, [...]
Hemostemix Announces Two New Strategic Trial Sites in Texas
16/08/2018
CALGARY, Alberta, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM) is pleased to announce that it has received all approvals from two significant institutions to [...]
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
16/08/2018
SPRINT ® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE NEWSWIRE) -- SPR [...]
Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review
16/08/2018
April 1, 2019 PDUFA Target Goal Date Gimoti Brand Name Conditionally Accepted SOLANA BEACH, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on [...]
Terra Tech Corp. CEO Derek Peterson to speak at Upcoming Cannabis Events
16/08/2018
IRVINE, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that it’s Chairman [...]
Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
16/08/2018
- First Patient Dosed with LN-145 in Phase 2 Trial with MD Anderson for Treatment of Sarcomas and Ovarian Cancer - - Preliminary Data from Moffitt NSCLC Study to be Presented at the Upcoming 19th World Conference on [...]
Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab
16/08/2018
One of three ongoing oncology combination studies coupling Inovio’s T cell enhancers with checkpoint inhibitors PLYMOUTH MEETING, Pa., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today [...]
Matinas BioPharma to Present at the U.S. FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
16/08/2018
BEDMINSTER, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of life-changing [...]
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
16/08/2018
Investigational WVE-210201 in development for treatment of Duchenne muscular dystrophy patients amenable to exon 51 skipping CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a [...]
Lawrence Lamb, Ph.D. Incysus Therapeutics Scientific Co-Founder to Present at 10th Annual Bioprocessing Summit
16/08/2018
NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today [...]
Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
16/08/2018
Former Celgene President & COO Joins Spring Bank Board HOPKINTON, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel [...]
Immutep to Present at the BioCentury 25th Annual NewsMakers in the Biotech Industry Conference
16/08/2018
SYDNEY, Australia, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
NanoVibronix Provides Business Update for the Second Quarter of 2018
16/08/2018
Revenue increases 153% for the second quarter of 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low [...]
Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018
16/08/2018
Early stage ophthalmology and anti-inflammation pipeline projects highlighted FRAMINGHAM, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of AC5™ [...]

Pages